Reports

Industry Research Reports

Global Biological Surfactant Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Biological Surfactant Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 138 Pages

Report ld: 5284669

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Biological Surfactant market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Detergents accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Biological Surfactant leading manufacturers including Evonik, Agae Technologies, Biotensidon, Ecover, Jeneil Biotech, Logos Technologies, MG Intobio, Saraya Co., Soliance, Urumqi Unite, etc., dominate supply; the top five capture approximately % of global revenue, with Evonik leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Biological Surfactant market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Evonik
  • Agae Technologies
  • Biotensidon
  • Ecover
  • Jeneil Biotech
  • Logos Technologies
  • MG Intobio
  • Saraya Co.
  • Soliance
  • Urumqi Unite

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Glycolipids
  • Lipopeptides and Lipoproteins
  • Phospholipids and Fatty Acids
  • Polymeric Biosurfactants
  • Particulate Biosurfactants

Segment by Application

  • Detergents
  • Personal Care
  • Food Processing
  • Agricultural Chemicals
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Biological Surfactant study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Biological Surfactant: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Biological Surfactant Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Glycolipids

1.2.3 Lipopeptides and Lipoproteins

1.2.4 Phospholipids and Fatty Acids

1.2.5 Polymeric Biosurfactants

1.2.6 Particulate Biosurfactants

1.3 Market Segmentation by Application

1.3.1 Global Biological Surfactant Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Detergents

1.3.3 Personal Care

1.3.4 Food Processing

1.3.5 Agricultural Chemicals

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Biological Surfactant Revenue Estimates and Forecasts 2020-2031

2.2 Global Biological Surfactant Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Biological Surfactant Sales Estimates and Forecasts 2020-2031

2.4 Global Biological Surfactant Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global Biological Surfactant Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global Biological Surfactant Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Biological Surfactant Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Glycolipids Market Size by Manufacturers

4.5.2 Lipopeptides and Lipoproteins Market Size by Manufacturers

4.5.3 Phospholipids and Fatty Acids Market Size by Manufacturers

4.5.4 Polymeric Biosurfactants Market Size by Manufacturers

4.5.5 Particulate Biosurfactants Market Size by Manufacturers

4.6 Global Biological Surfactant Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global Biological Surfactant Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Biological Surfactant Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global Biological Surfactant Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Biological Surfactant Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Biological Surfactant Sales and Revenue by Type (2020-2031)

7.4 North America Biological Surfactant Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Biological Surfactant Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Biological Surfactant Sales and Revenue by Type (2020-2031)

8.4 Europe Biological Surfactant Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Biological Surfactant Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Biological Surfactant Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Biological Surfactant Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Biological Surfactant Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Biological Surfactant Sales and Revenue by Type (2020-2031)

10.4 Central and South America Biological Surfactant Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Biological Surfactant Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Biological Surfactant Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Biological Surfactant Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Biological Surfactant Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 Evonik

12.1.1 Evonik Corporation Information

12.1.2 Evonik Business Overview

12.1.3 Evonik Biological Surfactant Product Models, Descriptions and Specifications

12.1.4 Evonik Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Evonik Biological Surfactant Sales by Product in 2024

12.1.6 Evonik Biological Surfactant Sales by Application in 2024

12.1.7 Evonik Biological Surfactant Sales by Geographic Area in 2024

12.1.8 Evonik Biological Surfactant SWOT Analysis

12.1.9 Evonik Recent Developments

12.2 Agae Technologies

12.2.1 Agae Technologies Corporation Information

12.2.2 Agae Technologies Business Overview

12.2.3 Agae Technologies Biological Surfactant Product Models, Descriptions and Specifications

12.2.4 Agae Technologies Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Agae Technologies Biological Surfactant Sales by Product in 2024

12.2.6 Agae Technologies Biological Surfactant Sales by Application in 2024

12.2.7 Agae Technologies Biological Surfactant Sales by Geographic Area in 2024

12.2.8 Agae Technologies Biological Surfactant SWOT Analysis

12.2.9 Agae Technologies Recent Developments

12.3 Biotensidon

12.3.1 Biotensidon Corporation Information

12.3.2 Biotensidon Business Overview

12.3.3 Biotensidon Biological Surfactant Product Models, Descriptions and Specifications

12.3.4 Biotensidon Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Biotensidon Biological Surfactant Sales by Product in 2024

12.3.6 Biotensidon Biological Surfactant Sales by Application in 2024

12.3.7 Biotensidon Biological Surfactant Sales by Geographic Area in 2024

12.3.8 Biotensidon Biological Surfactant SWOT Analysis

12.3.9 Biotensidon Recent Developments

12.4 Ecover

12.4.1 Ecover Corporation Information

12.4.2 Ecover Business Overview

12.4.3 Ecover Biological Surfactant Product Models, Descriptions and Specifications

12.4.4 Ecover Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Ecover Biological Surfactant Sales by Product in 2024

12.4.6 Ecover Biological Surfactant Sales by Application in 2024

12.4.7 Ecover Biological Surfactant Sales by Geographic Area in 2024

12.4.8 Ecover Biological Surfactant SWOT Analysis

12.4.9 Ecover Recent Developments

12.5 Jeneil Biotech

12.5.1 Jeneil Biotech Corporation Information

12.5.2 Jeneil Biotech Business Overview

12.5.3 Jeneil Biotech Biological Surfactant Product Models, Descriptions and Specifications

12.5.4 Jeneil Biotech Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Jeneil Biotech Biological Surfactant Sales by Product in 2024

12.5.6 Jeneil Biotech Biological Surfactant Sales by Application in 2024

12.5.7 Jeneil Biotech Biological Surfactant Sales by Geographic Area in 2024

12.5.8 Jeneil Biotech Biological Surfactant SWOT Analysis

12.5.9 Jeneil Biotech Recent Developments

12.6 Logos Technologies

12.6.1 Logos Technologies Corporation Information

12.6.2 Logos Technologies Business Overview

12.6.3 Logos Technologies Biological Surfactant Product Models, Descriptions and Specifications

12.6.4 Logos Technologies Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Logos Technologies Recent Developments

12.7 MG Intobio

12.7.1 MG Intobio Corporation Information

12.7.2 MG Intobio Business Overview

12.7.3 MG Intobio Biological Surfactant Product Models, Descriptions and Specifications

12.7.4 MG Intobio Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 MG Intobio Recent Developments

12.8 Saraya Co.

12.8.1 Saraya Co. Corporation Information

12.8.2 Saraya Co. Business Overview

12.8.3 Saraya Co. Biological Surfactant Product Models, Descriptions and Specifications

12.8.4 Saraya Co. Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Saraya Co. Recent Developments

12.9 Soliance

12.9.1 Soliance Corporation Information

12.9.2 Soliance Business Overview

12.9.3 Soliance Biological Surfactant Product Models, Descriptions and Specifications

12.9.4 Soliance Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Soliance Recent Developments

12.10 Urumqi Unite

12.10.1 Urumqi Unite Corporation Information

12.10.2 Urumqi Unite Business Overview

12.10.3 Urumqi Unite Biological Surfactant Product Models, Descriptions and Specifications

12.10.4 Urumqi Unite Biological Surfactant Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Urumqi Unite Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 Biological Surfactant Industry Chain

13.2 Biological Surfactant Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Biological Surfactant Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Biological Surfactant Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 Biological Surfactant Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global Biological Surfactant Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Biological Surfactant Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biological Surfactant Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biological Surfactant Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biological Surfactant Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biological Surfactant Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Biological Surfactant Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global Biological Surfactant Sales by Region (2020-2025) & (K MT)
Table 8. Global Biological Surfactant Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Biological Surfactant Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global Biological Surfactant Production by Region (2020-2025) & (K MT)
Table 12. Global Biological Surfactant Production by Region (2026-2031) & (K MT)
Table 13. Global Biological Surfactant Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global Biological Surfactant Sales Share by Manufacturers (2020-2025)
Table 15. Global Biological Surfactant Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Biological Surfactant Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Biological Surfactant by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Surfactant as of 2024)
Table 19. Global Biological Surfactant Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Biological Surfactant Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Biological Surfactant Manufacturing Base and Headquarters
Table 22. Global Biological Surfactant Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Biological Surfactant Sales by Type (2020-2025) & (K MT)
Table 26. Global Biological Surfactant Sales by Type (2026-2031) & (K MT)
Table 27. Global Biological Surfactant Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Biological Surfactant Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Biological Surfactant ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Biological Surfactant Sales by Application (2020-2025) & (K MT)
Table 32. Global Biological Surfactant Sales by Application (2026-2031) & (K MT)
Table 33. Biological Surfactant High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Biological Surfactant Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Biological Surfactant Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Biological Surfactant ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Biological Surfactant Growth Accelerators and Market Barriers
Table 40. North America Biological Surfactant Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Biological Surfactant Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Biological Surfactant Growth Accelerators and Market Barriers
Table 43. Europe Biological Surfactant Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Biological Surfactant Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Biological Surfactant Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Biological Surfactant Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Biological Surfactant Growth Accelerators and Market Barriers
Table 48. Southeast Asia Biological Surfactant Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Biological Surfactant Investment Opportunities and Key Challenges
Table 50. Central and South America Biological Surfactant Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Biological Surfactant Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Biological Surfactant Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Evonik Corporation Information
Table 54. Evonik Description and Major Businesses
Table 55. Evonik Product Models, Descriptions and Specifications
Table 56. Evonik Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Evonik Sales Value Proportion by Product in 2024
Table 58. Evonik Sales Value Proportion by Application in 2024
Table 59. Evonik Sales Value Proportion by Geographic Area in 2024
Table 60. Evonik Biological Surfactant SWOT Analysis
Table 61. Evonik Recent Developments
Table 62. Agae Technologies Corporation Information
Table 63. Agae Technologies Description and Major Businesses
Table 64. Agae Technologies Product Models, Descriptions and Specifications
Table 65. Agae Technologies Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. Agae Technologies Sales Value Proportion by Product in 2024
Table 67. Agae Technologies Sales Value Proportion by Application in 2024
Table 68. Agae Technologies Sales Value Proportion by Geographic Area in 2024
Table 69. Agae Technologies Biological Surfactant SWOT Analysis
Table 70. Agae Technologies Recent Developments
Table 71. Biotensidon Corporation Information
Table 72. Biotensidon Description and Major Businesses
Table 73. Biotensidon Product Models, Descriptions and Specifications
Table 74. Biotensidon Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Biotensidon Sales Value Proportion by Product in 2024
Table 76. Biotensidon Sales Value Proportion by Application in 2024
Table 77. Biotensidon Sales Value Proportion by Geographic Area in 2024
Table 78. Biotensidon Biological Surfactant SWOT Analysis
Table 79. Biotensidon Recent Developments
Table 80. Ecover Corporation Information
Table 81. Ecover Description and Major Businesses
Table 82. Ecover Product Models, Descriptions and Specifications
Table 83. Ecover Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Ecover Sales Value Proportion by Product in 2024
Table 85. Ecover Sales Value Proportion by Application in 2024
Table 86. Ecover Sales Value Proportion by Geographic Area in 2024
Table 87. Ecover Biological Surfactant SWOT Analysis
Table 88. Ecover Recent Developments
Table 89. Jeneil Biotech Corporation Information
Table 90. Jeneil Biotech Description and Major Businesses
Table 91. Jeneil Biotech Product Models, Descriptions and Specifications
Table 92. Jeneil Biotech Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Jeneil Biotech Sales Value Proportion by Product in 2024
Table 94. Jeneil Biotech Sales Value Proportion by Application in 2024
Table 95. Jeneil Biotech Sales Value Proportion by Geographic Area in 2024
Table 96. Jeneil Biotech Biological Surfactant SWOT Analysis
Table 97. Jeneil Biotech Recent Developments
Table 98. Logos Technologies Corporation Information
Table 99. Logos Technologies Description and Major Businesses
Table 100. Logos Technologies Product Models, Descriptions and Specifications
Table 101. Logos Technologies Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Logos Technologies Recent Developments
Table 103. MG Intobio Corporation Information
Table 104. MG Intobio Description and Major Businesses
Table 105. MG Intobio Product Models, Descriptions and Specifications
Table 106. MG Intobio Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. MG Intobio Recent Developments
Table 108. Saraya Co. Corporation Information
Table 109. Saraya Co. Description and Major Businesses
Table 110. Saraya Co. Product Models, Descriptions and Specifications
Table 111. Saraya Co. Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Saraya Co. Recent Developments
Table 113. Soliance Corporation Information
Table 114. Soliance Description and Major Businesses
Table 115. Soliance Product Models, Descriptions and Specifications
Table 116. Soliance Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Soliance Recent Developments
Table 118. Urumqi Unite Corporation Information
Table 119. Urumqi Unite Description and Major Businesses
Table 120. Urumqi Unite Product Models, Descriptions and Specifications
Table 121. Urumqi Unite Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Urumqi Unite Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Biological Surfactant Product Picture
Figure 2. Global Biological Surfactant Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Glycolipids Product Picture
Figure 4. Lipopeptides and Lipoproteins Product Picture
Figure 5. Phospholipids and Fatty Acids Product Picture
Figure 6. Polymeric Biosurfactants Product Picture
Figure 7. Particulate Biosurfactants Product Picture
Figure 8. Global Biological Surfactant Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Detergents
Figure 10. Personal Care
Figure 11. Food Processing
Figure 12. Agricultural Chemicals
Figure 13. Others
Figure 14. Biological Surfactant Report Years Considered
Figure 15. Global Biological Surfactant Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 17. Global Biological Surfactant Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 18. Global Biological Surfactant Revenue Market Share by Region (2020-2031)
Figure 19. Global Biological Surfactant Sales (2020-2031) & (K MT)
Figure 20. Global Biological Surfactant Sales (CAGR) by Region (2020-2031) (K MT)
Figure 21. Global Biological Surfactant Sales Market Share by Region (2020-2031)
Figure 22. Global Biological Surfactant Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 23. Global Biological Surfactant Production Trend by Region (2020-2031) (K MT)
Figure 24. Global Biological Surfactant Production Market Share by Region (2020-2031)
Figure 25. Production Capacity Enablers & Constraints
Figure 26. Biological Surfactant Production Growth Rate in North America (2020-2031) & (K MT)
Figure 27. Biological Surfactant Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 28. Biological Surfactant Production Growth Rate in China (2020-2031) & (K MT)
Figure 29. Biological Surfactant Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 30. Top 5 and Top 10 Manufacturers Biological Surfactant Sales Volume Market Share in 2024
Figure 31. Global Biological Surfactant Revenue Market Share Ranking (2024)
Figure 32. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 33. Glycolipids Revenue Market Share by Manufacturer in 2024
Figure 34. Lipopeptides and Lipoproteins Revenue Market Share by Manufacturer in 2024
Figure 35. Phospholipids and Fatty Acids Revenue Market Share by Manufacturer in 2024
Figure 36. Polymeric Biosurfactants Revenue Market Share by Manufacturer in 2024
Figure 37. Particulate Biosurfactants Revenue Market Share by Manufacturer in 2024
Figure 38. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 39. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 40. Global Biological Surfactant Sales Market Share by Type (2020-2031)
Figure 41. Global Biological Surfactant Revenue Market Share by Type (2020-2031)
Figure 42. Global Biological Surfactant Sales Market Share by Application (2020-2031)
Figure 43. Global Biological Surfactant Revenue Market Share by Application (2020-2031)
Figure 44. North America Biological Surfactant Sales YoY (2020-2031) & (K MT)
Figure 45. North America Biological Surfactant Revenue YoY (2020-2031) & (US$ Million)
Figure 46. North America Top 5 Manufacturers Biological Surfactant Sales Revenue (US$ Million) in 2024
Figure 47. North America Biological Surfactant Sales Volume (K MT) by Type (2020- 2031)
Figure 48. North America Biological Surfactant Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 49. North America Biological Surfactant Sales Volume (K MT) by Application (2020-2031)
Figure 50. North America Biological Surfactant Sales Revenue (US$ Million) by Application (2020-2031)
Figure 51. US Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 52. Canada Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 53. Mexico Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 54. Europe Biological Surfactant Sales YoY (2020-2031) & (K MT)
Figure 55. Europe Biological Surfactant Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Europe Top 5 Manufacturers Biological Surfactant Sales Revenue (US$ Million) in 2024
Figure 57. Europe Biological Surfactant Sales Volume (K MT) by Type (2020-2031)
Figure 58. Europe Biological Surfactant Sales Revenue (US$ Million) by Type (2020-2031)
Figure 59. Europe Biological Surfactant Sales Volume (K MT) by Application (2020-2031)
Figure 60. Europe Biological Surfactant Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Germany Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 62. France Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 63. U.K. Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 64. Italy Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 65. Russia Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 66. Asia-Pacific Biological Surfactant Sales YoY (2020-2031) & (K MT)
Figure 67. Asia-Pacific Biological Surfactant Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Asia-Pacific Top 8 Manufacturers Biological Surfactant Sales Revenue (US$ Million) in 2024
Figure 69. Asia-Pacific Biological Surfactant Sales Volume (K MT) by Type (2020- 2031)
Figure 70. Asia-Pacific Biological Surfactant Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 71. Asia-Pacific Biological Surfactant Sales Volume (K MT) by Application (2020-2031)
Figure 72. Asia-Pacific Biological Surfactant Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Indonesia Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 74. Japan Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 75. South Korea Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 76. China Taiwan Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 77. India Biological Surfactant Revenue (2020-2031) & (US$ Million)
Figure 78. Central and South America Biological Surfactant Sales YoY (2020-2031) & (K MT)
Figure 79. Central and South America Biological Surfactant Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Central and South America Top 5 Manufacturers Biological Surfactant Sales Revenue (US$ Million) in 2024
Figure 81. Central and South America Biological Surfactant Sales Volume (K MT) by Type (2021-2031)
Figure 82. Central and South America Biological Surfactant Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Central and South America Biological Surfactant Sales Volume (K MT) by Application (2020-2031)
Figure 84. Central and South America Biological Surfactant Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. Brazil Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 86. Argentina Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 87. Middle East, and Africa Biological Surfactant Sales YoY (2020-2031) & (K MT)
Figure 88. Middle East and Africa Biological Surfactant Revenue YoY (2020-2031) & (US$ Million)
Figure 89. Middle East and Africa Top 5 Manufacturers Biological Surfactant Sales Revenue (US$ Million) in 2024
Figure 90. Middle East and Africa Biological Surfactant Sales Volume (K MT) by Type (2021-2031)
Figure 91. South America Biological Surfactant Sales Revenue (US$ Million) by Type (2020-2031)
Figure 92. Middle East and Africa Biological Surfactant Sales Volume (K MT) by Application (2020-2031)
Figure 93. Middle East and Africa Biological Surfactant Sales Revenue (US$ Million) by Application (2020-2031)
Figure 94. GCC Countries Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 95. Turkey Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 96. Egypt Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 97. South Africa Biological Surfactant Revenue (2020-2025) & (US$ Million)
Figure 98. Biological Surfactant Industry Chain Mapping
Figure 99. Regional Biological Surfactant Manufacturing Base Distribution (%)
Figure 100. Biological Surfactant Production Process
Figure 101. Regional Biological Surfactant Production Cost Structure
Figure 102. Channels of Distribution (Direct Vs Distribution)
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Biological Surfactant market?zhanKai
The top companies in the global Biological Surfactant market are Evonik、Agae Technologies、Biotensidon.
den_biaoTiZhungShi

Related Reports

Global Biological Surfactant Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 138 Pages

Report ld: 5284669

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now